REXN - Rexahn Pharmaceuticals Inc.
Close
1.81
-0.060 -3.315%
Share volume: 0
Last Updated: Thu 05 Nov 2020 10:00:01 PM CET
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
$1.87
-0.06
-3.21%
Summary score
29%
Profitability
31%
Dept financing
26%
Liquidity
24%
Performance
28%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-162.73%
Return on assets
-21.19%
Return on sales
0%
Return on invested capital
185.71%
Total debt ratio
37.01%
Debt ratio change over timeo
-0.54%
Current Ratio
8.31%
Quick Ratio
0%
Cash Position Ratio
3.28%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-19.74%
Return on assets
-20.83%
Return on sales
0%
Return on invested capital
91.99%
Total debt ratio
24.14%
Debt ratio change over timeo
-0.79%
Current Ratio
5.59%
Quick Ratio
0%
Cash Position Ratio
2.48%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
-16.67%
Return on assets
-15.22%
Return on sales
0%
Return on invested capital
73.76%
Total debt ratio
21.53%
Debt ratio change over time
-0.72%
Current Ratio
4.88%
Quick Ratio
0%
Cash Position Ratio
2.64%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-640.52%
Return on assets
-120.5%
Return on sales
0%
Return on invested capital
357.82%
Total debt ratio
-53.63%
Debt ratio change over time
-0.54%
Current Ratio
5.88%
Quick Ratio
0%
Cash Position Ratio
2.16%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | REXN | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -162.73% | -40.29% | -10.93% | -12.25% |
| Return on assets | -21.19% | -20.88% | -8.71% | -9.49% |
| Return on sales | 0% | -5539.23% | 0% | -349.39% |
| Return on invested capital | 185.71% | 357.45% | -231.55% | -117.39% |
| Profitability | 38% | 25% | 50% | 0% |
| Total debt ratio | 37.01% | 131.74% | 25.21% | 26.21% |
| Debt ratio change over time | -0.54% | 0.02% | -1.1% | -1.45% |
| Dept financing | 7% | 50% | 5% | 5% |
| Current Ratio | 5.59% | 10.06% | 7.48% | 6.32% |
| Quick Ratio | 0% | 0% | 0% | 5.96% |
| Cash Position Ratio | 2.48% | 9.8% | 3.55% | 1.46% |
| Liquididy | 34% | 47% | 26% | 59% |
| Short-term ratios | REXN | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -19.74% | -134.4% | -16.25% | -15.11% |
| Return on assets | -20.83% | -19.61% | -12.33% | -8.32% |
| Return on sales | 0% | 0% | 0% | -378.27% |
| Return on invested capital | 91.99% | 708.86% | -51.57% | -40.11% |
| Profitability | 28% | 25% | 0% | 50% |
| Total debt ratio | 24.14% | 70.42% | 25.76% | 44.15% |
| Debt ratio change over time | -0.79% | -0.86% | -1.68% | -2.16% |
| Dept financing | 34% | 25% | 9% | 16% |
| Current Ratio | 5.59% | 10.06% | 7.48% | 6.32% |
| Quick Ratio | 0% | 0% | 0% | 5.96% |
| Cash Position Ratio | 2.48% | 9.8% | 3.55% | 1.46% |
| Liquididy | 20% | 50% | 28% | 44% |